论文信息 - Cimetidine treatment of protein-losing gastropathy (Ménétrier's disease). A clinical and pathophysiological study.

Cimetidine treatment of protein-losing gastropathy (Ménétrier's disease). A clinical and pathophysiological study.

In a 47-year-old male with Ménétrier's disease (protein-losing gastropathy) the histamine-H2-receptor antagonist Cimetidine stops the protein loss and improves the clinical condition. Gastric perfusion studies on net and bidirectional ionic fluxes, protein secretion rates, and permeability, with simultaneous recording of the transmural electrical potential difference indicate that Cimetidine decreases a paracellular protein secretion by 'tightening' the tight junctions of the gastric epithelium.

J. Henriksen | E. Krag | N. Olsen | H. Frederiksen

[1] J. Smith,et al. Menetrier's disease. Effect of medical and surgical vagotomy. , 1977, Mayo Clinic proceedings.

[2] J. D. Matthews,et al. Prednisolone in giant hypertrophic gastritis (Menetrier's disease) , 1976, The American journal of digestive diseases.

[3] J. Freston,et al. Ménétriers Disease: Serial Morphological, Secretory, and Serological Observations , 1976 .

[4] K. Ivey,et al. EFFECT OF CIMETIDINE ON GASTRIC POTENTIAL DIFFERENCE IN MAN , 1975, The Lancet.

[5] M. Yssing,et al. Quantitation of gastrointestinal protein loss by means of FE59-labeled iron dextran. , 1968, Gastroenterology.

[6] C. Laurell,et al. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. , 1966, Analytical biochemistry.

[7] Hans H. Ussing,et al. The Distinction by Means of Tracers Between Active Transport and Diffusion , 1949 .

[8] Stig Jarnum. gastritis): Evidence of non-selective protein loss1 , 2006 .

[9] B. Overholt,et al. Hypertrophic, hypersecretory protein-losing gastropathy. , 1970, Gastroenterology.